Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Update on dermal substitutes.

Michael Ehrenreich¹, Zbigniew Ruszczak

¹Dermatology, New Jersey Medical School, 185 South Orange Avenue, Newark 07103, USA. ehrenrmi@umdnj.edu

Acta Dermatovenerologica Croatica : ADC

|October 3, 2006

Summary

Tissue-engineered skin substitutes show promise for wound healing. While some cell-based products face market challenges, acellular dermal matrices like AlloDerm and Integra Bilayer Matrix Wound Dressing (BMWD) are gaining clinical acceptance for various wounds.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Erythema dyschromicum perstans following influenza vaccine.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024

Same author

Chronic granulomatous disease in the United Arab Emirates: clinical and molecular characteristics in a single center.

Frontiers in immunology·2023

Same author

Personal protective equipment-related dermatoses in COVID-19 frontline health workers. A lesson learned from 1-year single center in the UAE.

Dermatologic therapy·2022

Same author

Chanarin-Dorfman syndrome treatment with acitretin.

JAAD case reports·2022

Same author

Interrupting aerosol spread and nasal acquisition of SARS-CoV-2 with topical trichloroacetic acid.

Italian journal of dermatology and venereology·2022

Same author

COVID-19: Topical agents and therapeutic prevention of nasal viral acquisition.

Dermatologic therapy·2020

Area of Science:

Regenerative Medicine
Biomaterials Science
Wound Healing Research

Background:

Tissue-engineered biological dressings hold potential for treating burns, chronic ulcers, surgical wounds, and dermatologic conditions.
Cellular products like Dermagraft and Apligraf have experienced market share limitations.
Acellular dermal matrices and bilayer matrix wound dressings represent alternative technologies gaining traction.

Purpose of the Study:

To review the current landscape of tissue-engineered biological dressings.
To compare the market progress and clinical acceptance of different wound dressing technologies.
To highlight the growing adoption of acellular and bilayer matrix wound dressings.

Main Methods:

Literature review of commercially available tissue-engineered wound dressings.
Analysis of market performance and clinical adoption trends.
Comparative assessment of cell-based vs. acellular and bilayer matrix products.

Main Results:

Cellular tissue-engineered products have not met initial market expectations.
Acellular dermal matrix (AlloDerm) and Integra Bilayer Matrix Wound Dressing (BMWD) demonstrate increasing clinical acceptance.
Integra BMWD is expanding its use beyond its initial indication for burns.

Conclusions:

Acellular and bilayer matrix wound dressings are achieving greater clinical and market success than some earlier cell-based products.
The review provides insights into the evolving market dynamics of advanced wound care technologies.
Continued evaluation of these advanced wound care products is warranted.

Related Experiment Videos